Recall archive / FDA device enforcement
Medline medical procedure kits labeled as follows: a) ANESTHESIA CIRCUIT ADULT, REF DYNJAAF6666B; b) ANESTHESIA CIRCU... — FDA record Z-2700-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Mar 22, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Medline medical procedure kits labeled as follows: a) ANESTHESIA CIRCUIT ADULT, REF DYNJAAF6666B; b) ANESTHESIA CIRCUIT PEDS-LF, REF DYNJAP9918A; c) CV ANESTHESIA - ROOM SET UP, REF DYNJ905503F
- Reason
- A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
- Classification
- Class II
- Recalling firm
- MEDLINE INDUSTRIES, LP - Northfield
- Quantity
- 1920 units
- Agency-reported status
- Ongoing
- Source record identifier
- Z-2700-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | a) REF DYNJAAF6666B, UDI/DI 40195327505838 (case), 10195327505837 (unit), Lot Numbers: 22EBD700, 22GBK692, 22KBE980, 23DBF522, 23GBU504, 23IBJ329, 23LBD558; b) REF DYNJAP9918A, UDI/DI 40195327505883 (case), 10195327505882 (unit), Lot Numbers: 22EBC460, 22HBK483, 22IBT280, 22JBC030, 22KBG647, 23IBM414; c) REF DYNJ905503F, UDI/DI 40889942131410 (case), 10889942131419 (unit), Lot Numbers: 22FBR267, 22GBR286, 22HBS560, 22IBA577, 22JBI883, 22KBD587, 22LBF425, 23BBN903, 23CBL450, 23CBW776, 23FBC209, 23IBU343, 23JBP494, 23KBH749, 23KBQ236 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Worldwide - US Nationwide and the countries of Panama, Mexico, Canada, Qatar, El Salvador, Oman, Colombia, Singapore.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Aug 28, 2024
- Recall initiation date
- Mar 22, 2024
- Center classification date
- Aug 22, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.